Resultados da busca - Francesco Di Raimondo

Refinar Resultados
  1. 1
    Management of Chronic Myeloid Leukemia in Advanced Phase

    Management of Chronic Myeloid Leukemia in Advanced Phase por Massimiliano Bonifacio, Fabio Stagno, Luigi Scaffidi, Mauro Krampera, Francesco Di Raimondo

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs

    Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs por Stefania Stella, Elena Tirrò, Enrico Conte, Fabio Stagno, Francesco Di Raimondo, Livia Manzella, Paolo Vigneri

    Publicado em 2013
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Immunological Dysregulation in Multiple Myeloma Microenvironment

    Immunological Dysregulation in Multiple Myeloma Microenvironment por Alessandra Romano, Concetta Conticello, Maide Cavalli, Calogero Vetro, Alessia La Fauci, Nunziatina Laura Parrinello, Francesco Di Raimondo

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology

    Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology por Grazia Scuderi, Katia Mangano, Maria Cristina Petralia, Maria Sofia Basile, Francesco Di Raimondo, Paolo Fagone, Ferdinando Nicoletti

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia

    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia por Marco Montillo, Alessandra Tedeschi, Susan O’Brien, Francesco Di Raimondo, Susan Lerner, Alessandra Ferrajoli, Enrica Morra, Michael J. Keating

    Publicado em 2002
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells

    Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells por Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, Luca Vanella, Concetta Conticello, Alessandra Romano, Salvatore Saccone, Justyna Godos, Francesco Di Raimondo, Giovanni Li Volti

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis

    Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis por Francesco Di Raimondo, MP Azzaro, Giuseppe A. Palumbo, Sabrina Bagnato, Fabio Stagno, GM Giustolisi, Emma Cacciola, Grazia Sortino, Patrizia Guglielmo, Rosario Giustolisi

    Publicado em 2001
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future

    Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future por Andrea Duminuco, Antonella Nardo, Gaetano Giuffrida, Salvatore Leotta, Uroš Markovic, Cesarina Giallongo, Daniele Tibullo, Alessandra Romano, Francesco Di Raimondo, Giuseppe A. Palumbo

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  9. 9
    Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapy

    Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapy por Raffaele Palmieri, Anna Candoni, Francesco Di Raimondo, Giuseppe Rossi, Massimo Breccia, Fabrizio Pane, Paola Volpicelli, Benedetta Neri, Paola Finsinger, Morena Caira, Felicetto Ferrara

    Publicado em 2025
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  10. 10
    Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia

    Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia por Michele Massimino, Stefania Stella, Elena Tirrò, Chiara Romano, Maria Stella Pennisi, Adriana Puma, Livia Manzella, Antonio Zanghì, Fabio Stagno, Francesco Di Raimondo, Paolo Vigneri

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  11. 11
    Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

    Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents por Alessandra Romano, Nunziatina Laura Parrinello, Marzia L Consoli, Luigi Marchionni, Stefano Forte, Concetta Conticello, Alessandra Pompa, Alessandro Corso, Giuseppe Milone, Francesco Di Raimondo, Ivan Borrello

    Publicado em 2015
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy

    Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy por Alessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, Stefano Forte, Annalisa Chiarenza, Amalia Figuera, Giovanna Motta, Giuseppe A. Palumbo, Massimo Ippolito, Ugo Consoli, Francesco Di Raimondo

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview

    Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview por Alessandro Barbato, Grazia Scandura, Fabrizio Puglisi, Daniela Cambria, Enrico La Spina, Giuseppe A. Palumbo, Giacomo Lazzarino, Daniele Tibullo, Francesco Di Raimondo, Cesarina Giallongo, Alessandra Romano

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  14. 14
    Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an <i>ad hoc</i> expert panel

    Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an <i>ad hoc</i>... por Valerio De Stefano, Alessandra Larocca, Monica Carpenedo, Michèle Cavo, Francesco Di Raimondo, Anna Falanga, Massimo Offidani, Maria Teresa Petrucci, Marco Ruggeri, Roberto Santi, Giovanni Barosi

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients

    Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients por Cesarina Giallongo, Nunziatina Laura Parrinello, Daniele Tibullo, Piera La Cava, Alessandra Romano, Annalisa Chiarenza, Ignazio Barbagallo, Giuseppe A. Palumbo, Fabio Stagno, Paolo Vigneri, Francesco Di Raimondo

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors

    Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors por Katia Basso, Arcangelo Liso, Enrico Tiacci, Roberta Benedetti, Alessandro Pulsoni, Robin Foà, Francesco Di Raimondo, Achille Ambrosetti, Andrea Califano, Ulf Klein, Riccardo Dalla Favera, Brunangelo Falini

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine

    Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccin... por Giuseppe A. Palumbo, Daniela Cambria, Enrico La Spina, Andrea Duminuco, Antonio Laneri, Anna Longo, Calogero Vetro, Sebastiano Giallongo, Alessandra Romano, Francesco Di Raimondo, Daniele Tibullo, Cesarina Giallongo

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival

    Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival por Alessia Ongaro, Monica De Mattei, Matteo Giovanni Della Porta, Gian Matteo Rigolin, C Ambrósio, Francesco Di Raimondo, Agnese Pellati, Federica Francesca Masieri, Angelo Caruso, L. Catozzi, Donato Gemmati

    Publicado em 2009
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience

    Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience por Andrea Duminuco, Anna Bulla, Rosamaria Rosso, M. A. Romeo, Daniela Cambria, Enrico La Spina, Benedetta Ximenes, Cesarina Giallongo, Daniele Tibullo, Alessandra Romano, Francesco Di Raimondo, Giuseppe A. Palumbo

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib

    Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib por Cesarina Giallongo, Nunziatina Laura Parrinello, Piera La Cava, Giuseppina Camiolo, Alessandra Romano, Marina Scalia, Fabio Stagno, Giuseppe A. Palumbo, Roberto Avola, Giovanni Li Volti, Daniele Tibullo, Francesco Di Raimondo

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: